HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Market News Stocks News ETF News Crypto News

Protara Therapeutics

Contributing Author

Recent Articles by Protara Therapeutics

Dec-04
Protara Announces Pricing of $75 Million Public Offering TARA -18.78% GlobeNewswire
Dec-04
Protara Announces Proposed Public Offering TARA GlobeNewswire
Dec-03
Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naive NMIBC Patients TARA GlobeNewswire
Dec-01
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naive NMIBC Patients on Wednesday, December 3, 2025 TARA GlobeNewswire
Nov-19
Protara Therapeutics Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations TARA GlobeNewswire
Nov-18
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025 TARA GlobeNewswire
Nov-17
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naive NMIBC Patients at the 26th Annual Meeting of the Society of Urologic Oncology TARA GlobeNewswire
Nov-10
Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update TARA GlobeNewswire
Nov-04
Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace TARA GlobeNewswire
Oct-01
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire
Sep-02
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire
Aug-27
Protara Therapeutics to Participate in Upcoming Investor Conferences TARA GlobeNewswire
Aug-11
Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update TARA GlobeNewswire
Aug-01
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire
Jul-01
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire
Jun-30
Protara Therapeutics Announces Addition to the Russell 3000 Index TARA GlobeNewswire
Jun-02
Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer TARA GlobeNewswire
May-13
Protara Therapeutics to Participate in Upcoming Investor Conferences TARA GlobeNewswire
May-08
Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update TARA GlobeNewswire
May-01
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.